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Abstract  
Background 
Gallstone disease is a leading indication for non-obstetric abdominal surgery during 
pregnancy. There are limited whole population data on maternal and neonatal outcomes. This 
population-based study aims to describe the outcomes of gallstone disease during pregnancy 
in an Australian setting.  
 
Methods 
Linked hospital, birth and mortality data for all women with singleton pregnancies in 
New South Wales, Australia, 2001-2012 were analysed. Exposure of interest was gallstone 
disease (acute biliary pancreatitis, gallstones with/without cholecystitis). Outcomes including 
preterm birth (spontaneous and planned), readmission, morbidity and mortality (maternal and 
neonatal) were compared between pregnancies with and without gallstone disease and within 
disease subtypes. Adjusted risk ratios (aRRs) and 99% confidence intervals were estimated 
using modified Poisson regression and adjusted for maternal and pregnancy factors. 
 
Results 
Among 1,064,089 pregnancies, 1882 (0.18%) had gallstone disease.  Of these, 239 
(12.7%) had an antepartum cholecystectomy and 1643 (87.3%) were managed 
conservatively. Of those managed conservatively, 319 (19.0%) had a postpartum 
cholecystectomy.  Gallstone disease was associated with increased risk of preterm birth (aRR 
1.3, 99% CI 1.1, 1.6) particularly planned preterm birth (aRR 1.6, 99% CI 1.2, 2.1), maternal 
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morbidity (aRR 1.6, 99% CI 1.1, 2.3), maternal readmission (aRR 4.7, 99% CI 4.2, 5.3),  and 
neonatal morbidity (aRR 1.4, 99% CI 1.1, 1.7). Surgery was associated with decreased risk of 
maternal readmission (aRR 0.4, 99% CI 0.2, 0.7).  
 
Conclusions 
Gallstone disease during pregnancy was associated with adverse maternal and 
neonatal outcomes. Most women with gallstone disease during pregnancy are managed 
conservatively.  Surgical management was associated with decreased risk of readmission. 
 
Keywords 
pregnancy; hospitalisation; cholecystectomy; cholecystitis; morbidity  
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Introduction 
Symptomatic gallstone disease is a leading indication for emergency abdominal 
surgery during pregnancy along with suspected appendicitis and bowel obstruction.
1, 2
  
Pregnancy is associated with the formation of biliary sludge and gallstones as a result of the 
actions of oestrogen and progesterone promoting increased cholesterol secretion and biliary 
stasis.
3
  It is estimated that 0.05-0.8% of pregnant women have symptomatic gallstones.
2
  
Diagnosis and treatment of gallstone disease during pregnancy is challenging; 
balancing the risks and benefits to the mother and baby.  Non-surgical management is 
reportedly associated with high rates of symptom recurrence and the risk of disease 
progression;
2
 while surgery carries potential risks to the mother and baby from anaesthesia 
and radiation exposure from medical imaging.
4
   
Population-based data on maternal and neonatal outcomes is important for counselling 
pregnant women with gallstone disease. However, given the rarity of this pregnancy 
complication, much of the evidence on maternal and neonatal outcomes come from reviews 
and meta-analyses of single centre retrospective case series and reports.
2, 5, 6
  There are few 
population-based studies that have compared outcomes between pregnant and non-pregnant 
women; and there are no population data from an Australian context.
4
 
Longitudinally linked population health data provide a unique opportunity to examine 
gallstone disease identified during pregnancy and subsequent birth outcomes for mothers and 
babies. Using linked birth, hospital and mortality data, the primary aim of this study was to 
describe the maternal and neonatal outcomes associated with gallstone disease during 
pregnancy in an Australian setting. The secondary aim was to compare maternal and neonatal 
outcomes by gallstone disease management during pregnancy. 
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Methods 
Data sources and linkage 
The study population included all women with a singleton pregnancy in New South 
Wales (NSW) giving birth to a live or stillborn baby between 2001 and 2012.  Data from a 
number of sources were utilised.  Birth information was obtained from the NSW Perinatal 
Data Collection and was linked to hospital admissions information from the NSW Admitted 
Patient Data Collection; along with mortality information from the NSW Register of Births 
Deaths and Marriages and the NSW Perinatal Death Review database. The NSW Perinatal 
Data Collection captures maternal demographic, pregnancy and infant information on all live 
and stillbirths of at least 20 weeks gestation or 400 grams birthweight occurring at home and 
in public and private hospitals.  The NSW Admitted Patient Data Collection contains 
information on all hospital discharges from public, private and day procedure centres in 
NSW.  The Register of Births Deaths and Marriages holds vital statistics on all registered 
deaths in NSW; while the NSW Perinatal Death Review database contains information from 
confidential reviews of perinatal mortality cases.  Hospital admissions information was coded 
from medical records using the International Statistical Classification of Diseases and Related 
Health Problems, Australian modification (ICD10AM) for diagnoses and the Australian 
Classification of Health Interventions (ACHI) for procedures. Individual-level data linkage 
was conducted by the Centre for Health Record Linkage using probabilistic data matching 
methods;
7
 with false positive and negative rates of 0.5%.
8
  Ethics approval was obtained from 
the NSW Population and Health Services Research Ethics Committee (2012/12/430). 
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Study variables 
The exposure of interest was gallstone disease including acute biliary pancreatitis 
(K85.1), gallstones without cholecystitis (K80.2, K80.5), gallstones with cholangitis (K80.3) 
and gallstones with cholecystitis (K80.0, K80.4) identified among pregnancies using hospital 
admissions data. Pregnancies with cholecystitis without gallstones (K81.0) were excluded.  
The comparison group consisted of pregnancies without gallstone disease who also did not 
have any abdominal surgery such as cholecystectomy, appendicectomy, laparoscopy or 
laparotomy performed during pregnancy. Management of gallstone disease was determined 
by the presence of procedure codes for cholecystectomy (cholecystectomy group) or its 
absence (conservative management group) during pregnancy. The ascertainment of 
cholelithiasis (gallstones) and cholecystectomy from hospital data is high. Sensitivity and 
positive predictive values of 85% and 81% have been reported for cholelithiasis; 
9
 likewise 
sensitivity and positive predictive values of 80.5% and 98.5% have been reported for 
cholecystectomy.
10
  
Pregnancy outcomes assessed included antepartum and postpartum haemorrhage, 
onset of labour, mode of delivery, maternal readmission within 90 days of birth, maternal 
morbidity and mortality.  Maternal morbidity was a composite measure derived from birth 
and hospital data and occurring during the birth admission and included severe adverse 
outcomes such as cerebrovascular accident, shock, blood transfusion and cardiomyopathy.
11
 
Neonatal outcomes included preterm birth (<37 weeks gestation), small-for-
gestational age (<10
th
 population percentile for gestational age),
12
 low Apgar scores, neonatal 
morbidity and mortality. Preterm births were further classified as spontaneous or planned 
according to onset of labour. Planned births included labour induction and caesarean delivery 
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without labour. Neonatal morbidity was a composite measure of serious adverse outcomes 
including intraventricular haemorrhage, respiratory failure, sepsis, blood transfusion and 
body cavity surgical procedures occurring before the first discharge home and determined 
from birth and hospital admissions data.
13
  Perinatal mortality included stillbirth (fetal death 
of at least 20 weeks gestation or 400 grams birthweight) and neonatal death (death of 
liveborn infant within 28 days of birth); and was identified from birth, hospital admissions 
and mortality data. 
Other variables assessed included maternal age, parity, baby’s year of birth, maternal 
country of birth, smoking, diabetes, hypertension, socioeconomic status, gallstone disease 
subtype, whether multiple types of gallstone disease were present and the number,  length and 
gestational age at gallstone disease-related admissions.  Socioeconomic status was 
determined from maternal residential postcodes and the Australian Bureau of Statistics Index 
of Relative Socio Economic Disadvantage scores
14
 grouped into quintiles based on the 
distribution of the NSW obstetric population. 
 
Statistical analysis 
Characteristics of the study population were summarised using mean and standard 
deviation or median and interquartile range for continuous data, and frequency and 
proportions for categorical data. Lifetables were used to assess the proportion of undelivered 
pregnancies according to gestational age at the time of cholecystectomy compared with the 
proportion of undelivered pregnancies among women without gallstone disease. 
Outcomes were compared according to: presence or absence of gallstone disease and 
mode of management (surgical versus conservative management) using unadjusted and 
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adjusted risk ratios. Adjusted risk ratios with 99% confidence intervals were estimated using 
modified Poisson regression with robust variances and adjusted for potential confounding. In 
multivariable analyses comparing outcomes by gallstone disease status, potential confounders 
were selected a priori based on the literature and included maternal (age, socioeconomic 
status, country of birth) and pregnancy (parity, hypertension, diabetes and baby’s year of 
birth) factors. For comparisons by mode of management, potential confounders were 
included in multivariable analyses where p<0.05 in univariate analysis. Due to the number of 
comparisons made, statistical significance level was set at p<0.01 for multivariable models to 
reduce the probability of obtaining false positive results.Analyses were performed using SAS 
9.4 (SAS Institute, Cary, NC). 
 
 
Results 
A total of 1,092,058 pregnancies were recorded in New South Wales between 2001 
and 2012. Of these, 27969 (2.6%) pregnancies were excluded from analyses due to: multiple 
births (1.5%), missing hospital data (0.8%), gallstone disease diagnosis after pregnancy 
(0.2%) and abdominal surgery prior to pregnancy (0.1%).  There were less than 5 pregnancies 
diagnosed with gallstones with cholangitis and these pregnancies were excluded from further 
analyses.  
Characteristics and outcomes of women with gallstone disease 
Among the 1,064,089 eligible singleton pregnancies, 1882 (1.8 per 1000) had a 
diagnosis of gallstone disease during pregnancy. Of the pregnancies with gallstone disease, 
175 (9.3%) were diagnosed with multiple subtypes of gallstone disease. Women with 
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gallstone disease were more likely to be younger, multiparous and socioeconomically 
disadvantaged. There were also higher rates of maternal smoking, diabetes, hypertension and 
late preterm birth among pregnancies with gallstone disease compared to those without 
gallstone disease (Table 1).   
Gallstone disease was associated with increased risk of preterm birth (aRR 1.3, 99% 
CI 1.1, 1.6); particularly planned preterm births (aRR 1.6, 99% CI 1.2, 2.1) (Table 2). Of the 
155 preterm births among women with gallstone disease, 114 (73.5%) delivered at 34-36 
weeks gestation.  Compared to pregnancies without gallstone disease where 96.4% of 
pregnancies were undelivered at 36 weeks, the proportions of undelivered pregnancies by 
gestational age at the time of cholecystectomy were: 96.1%, 97.9% and 73.7% for 
cholecystectomies performed at less than 20 weeks, 20-28 weeks and 29-36 weeks, 
respectively. 
The risk of maternal morbidity and readmission for any reason was significantly 
higher among pregnancies with gallstone disease; as was the risk of neonatal morbidity and 
neonatal readmission to hospital within 28 days of birth (Table 2). Morbidity among infants 
born to mothers with gallstone disease included higher rates of respiratory distress/failure, 
ventilation support, blood vessel catheterisation, parenteral nutrition, and sepsis. Jaundice 
was the main reason for neonatal readmission. Among the gallstone disease group, there were 
no maternal deaths up to 90 days postpartum and the rate of maternal morbidity was 2.9%.  
There was no difference in the rate of stillbirths (0.4% vs 0.6%, aRR 0.7, 99% CI 0.3, 1.8) or 
perinatal deaths (0.6% vs 0.8%, aRR 0.7, 99% CI 0.3, 1.5) among pregnancies with or 
without gallstone disease. 
Hospitalisation and subtypes of gallstone disease 
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Among pregnant women with gallstone disease, 1462 (77.7%) had one gallstone-
related hospital admission and 420 (22.3%) had two or more such admissions.  Antepartum 
cholecystectomy was most frequently performed among pregnancies with acute biliary 
pancreatitis while the highest proportion of conservative management during pregnancy 
occurred among pregnancies with gallstones but no cholecystitis (Table 3). Of those managed 
conservatively, the rate of postpartum cholecystectomy was marginally higher among 
pregnancies with acute biliary pancreatitis (Table 3). Among 90 pregnancies with a diagnosis 
of acute biliary pancreatitis, 15 (16.7%) initially presented with other subtypes of gallstone 
disease.   
Management of gallstone disease 
Of the 1882 pregnancies with gallstone disease, 239 (12.7%) had an antepartum 
cholecystectomy while 1643 (87.3%) were managed conservatively.  A total of 28 
pregnancies (1.5%) had their cholecystectomy performed during the birth admission. Three 
hundred and twelve (19.0%) of those managed conservatively had a postpartum 
cholecystectomy. Sixty eight (28.5%) of antepartum cholecystectomies and 51 (16.3%) of 
postpartum cholecystectomies were performed in tertiary perinatal centres. Of the 551 
cholecystectomies performed, 523 (94.9%) were laparoscopic, 22 (4.0%) were open and 6 
(1.1%) were conversions from laparoscopic to open cholecystectomies.   
Maternal and neonatal outcomes by management 
Pregnancies with gallstone disease managed surgically had decreased risk of maternal 
readmission (Table 4). Similarly lower rates of maternal readmission with surgical 
management were observed among gallstone disease subgroups.  There were no differences 
in mode of delivery or preterm birth rates between surgical and conservative management. 
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While there was some evidence of low Apgar scores among pregnancies managed surgically, 
the results were not statistically significant after adjustment (Table 4). 
 
Comment 
Main findings 
The prevalence of gallstone disease during pregnancy among our study population 
was 1.8 per 1000 singleton pregnancies.  Gallstone disease during pregnancy was associated 
with increased risk of preterm birth, maternal and neonatal morbidity and hospital 
readmissions. The majority of pregnant women with gallstone disease were treated 
conservatively, although 19% of these women subsequently had a cholecystectomy in the 
postpartum period.  Antepartum surgical management of gallstone disease was associated 
with decreased risk of maternal readmission; however, there was no difference in the risk of 
preterm birth or maternal morbidity between surgical or conservative management.  
Interpretation 
The prevalence of gallstone disease among pregnant women in New South Wales 
between 2001 and 2012 was 0.18%, within the range of 0.05-0.8% previously reported.
2, 15
  
Likewise, the antepartum cholecystectomy rate within our population (12.7%) was similar to 
rates ranging from 13.2% to 17.9% reported for complicated symptomatic gallstone disease 
during pregnancy.
16, 17
  Our rate of conversion from laparoscopic to open cholecystectomy 
(1.1%) was slightly lower than the 2.2% rate reported by Nasioudis and colleagues in their 
meta-analysis of 51 studies involving laparoscopic cholecystectomies in 590 pregnancies 
over 1992-2015.
5
  Interestingly, around 70% of the laparoscopic cholecystectomies in the 
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meta-analysis were performed in the second trimester, compared with 44.8% and 38.1% of 
cholecystectomies performed in the second and first trimesters in our study.  
A number of risk factors for gallstone disease have been identified including high 
parity,
18
 obesity 
18, 19
 as well as diabetes.
18, 20
  Similar to these reports, we also found an 
overrepresentation of gallstone disease among pregnant women who were multiparous and 
those who had diabetes.  Although ascertainment of obesity in our data was low (0.4%) 
compared with other Australian reports of 12-20% prevalence among pregnant women 
21, 22
, 
we did find higher rates of obesity among women with gallstone disease (2.3% vs 0.4%).  
Furthermore, we also found higher rates of gallstone disease among pregnant women with 
diabetes and hypertension; both markers of obesity.  While an association between older 
maternal age and gallstone disease has been reported,
18
 our study found higher prevalence of 
gallstone disease among younger women (less than 35 years), a finding supported by at least 
one other study.
19
 
We found gallstone disease was associated with increased risk of preterm birth, 
maternal and neonatal morbidity (including neonatal intraventricular haemorrhage and 
respiratory distress) and hospital readmission.  Similarly, a US population cohort study 
reported increased odds of preterm birth, jaundice, small-for-gestational age, respiratory 
distress syndrome and intrauterine fetal death associated with pancreatitis.
23
  However, the 
aetiology of pancreatitis within the cohort was not specified and it has been reported that 
biliary pancreatitis has a milder course during pregnancy than other forms such as alcohol 
induced pancreatitis.
24
  In our study, the absolute rate of maternal morbidity was low (2.9%) 
and there were no cases of maternal mortality among the gallstone disease group.  These 
findings are encouraging, suggesting that there are no substantially increased risks of 
maternal morbidity or mortality for pregnancies complicated with gallstone disease. 
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Furthermore, the increased risk of preterm birth appears to be related to decisions to intervene 
rather than spontaneous preterm delivery. 
Guidelines recommend early surgical management of gallbladder disease during 
pregnancy; with laparoscopic cholecystectomy being the treatment of choice irrespective of 
pregnancy trimester.
25
  Early surgical management is recommended as delay is associated 
with increased rates of hospital admission, preterm labour and preterm delivery; as well as 
development of cholecystitis and pancreatitis.
25
  In our study, we found that the mean number 
of gallstone hospital admissions was low (1.2-1.3 admissions) and the median time from first 
presentation to antepartum cholecystectomy was short (ranging from two to six days); these 
would suggest early intervention is occurring. Encouragingly, fewer than 10% of women with 
gallstones and no pancreatitis had 3 or more gallstone-related admissions during their 
pregnancy. 
Most pregnant women in this study were managed conservatively; particularly for 
women who had biliary colic without cholecystitis or pancreatitis.  This may reflect the use of 
conservative management as the first line of treatment, with surgery reserved for failure of 
conservative management or recurrent gallstone disease.  Clinicians are reluctant to perform 
operative cholangiograms to visualise the gallbladder due to potential radiation exposure to 
the unborn baby.  This may additionally contribute to low antepartum cholecystectomy rates.  
In our study, we showed that pregnant women with acute biliary pancreatitis were 
more likely to be managed surgically compared to other types of gallbladder disease (32.5% 
vs 11.9%).  Furthermore, they were more likely to have a cholecystectomy in the postpartum 
period..  Acute biliary pancreatitis has been reported to be associated with high maternal and 
fetal mortality
15
 in the past, as well as high rates of recurrence with conservative 
management.
26
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Our study showed that surgical management of gallstone disease was associated with 
decreased risk of maternal hospital readmission, a finding that has been reported elsewhere.
17, 
27
  Also consistent with other reports,
2, 6
 we found no difference in rates of preterm birth or 
fetal mortality between surgically and conservatively managed pregnancies.   
 
Strengths of the study 
This study is to our knowledge the largest population-based study comparing maternal 
and neonatal outcomes between pregnant women with and without gallstone disease. Using 
routinely collected longitudinally-linked population data, we were able to: assess maternal 
and neonatal outcomes taking into account pregnancy and maternal factors, obtain 
representative population estimates of symptomatic gallstone disease prevalence, track 
progression of gallstone disease during pregnancy and determine gestational age at the time 
of diagnosis, surgery and delivery. Use of routinely collected population data minimised bias 
as a result of loss to follow up found in traditional cohort studies. Furthermore, use of whole 
population data minimises selection bias. 
Limitations of the data 
Limitations associated with using routinely collected data included missing 
information and possible misclassification. As the purpose of data collection was not 
specifically for this study, information on important and relevant risk factors and potential 
confounders may not be available. Restricting our cohort to gallstone disease during 
pregnancy meant we could not determine whether admissions for gallstone disease were due 
to newly-onset disease or recurrent attacks.  In addition, further analyses of gallstone disease 
management were limited by lack of clinical detail on important factors such as indication for 
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cholecystectomy and acuity of gallstone disease.  While case heterogeneity may be a factor in 
the use of routinely collected data, it has been shown that ascertainment of gallstones and 
cholecystectomy within administrative hospital data is high.
9, 10
 Given the non-specific nature 
of symptoms of gallstone disease it is possible some cases were misclassified to the no 
gallstone disease group; this would have the effect of biasing results towards the null.  
 
Conclusions 
In summary, gallstone disease during pregnancy is associated with increased risk of 
preterm birth, neonatal morbidity and maternal and neonatal readmission.  However, the 
prevalence is low and most women were managed conservatively.  Surgical management of 
gallstone disease is associated with decreased risk of maternal readmission and no difference 
was found in the rate of preterm birth or maternal morbidity between surgical or conservative 
management. In the majority of pregnant women with symptomatic gallstone disease, 
conservative management is a feasible option and appears to be standard practice. 
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Table 1:  Characteristics of 1,064,089 singleton pregnancies with and without gallstone disease in 
New South Wales, Australia, 2001-2012 
Characteristics 
Gallstone disease 
(N=1882) 
n (%) 
No gallstone disease 
(N=1062207) 
n (%) 
Maternal age, mean (sd) 28.3 (5.8) 30.0 (5.6) 
     Less than 20 109 (5.8) 37876 (3.6) 
     20-34 1479 (78.6) 793741 (74.7) 
     35+ 294 (15.6) 230373 (21.7) 
Parity   
     Primiparous 707 (37.7) 447128 (42.2) 
     1 611 (32.5) 355873 (33.6) 
     2+ 560 (29.8) 257698 (24.3) 
Maternal country of birth   
     Australia 1512 (80.3) 727918 (68.5) 
     South East Asia 43 (2.3) 57537 (5.4) 
     Other 327 (17.4) 276752 (26.1) 
Smoker 430 (22.9) 141659 (13.4) 
Diabetes 152 (8.1) 70074 (6.6) 
Hypertension 254 (13.5) 94135 (8.9) 
SEIFA (quintiles)   
     1 (most disadvantaged) 468 (24.9) 207647 (19.6) 
     2 443 (23.6) 212646 (20.1) 
     3 424 (22.6) 212266 (20.0) 
     4 331 (17.6) 213407 (20.2) 
     5 (least disadvantaged) 211 (11.2) 213117 (20.1) 
Gestational age at birth   
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Characteristics 
Gallstone disease 
(N=1882) 
n (%) 
No gallstone disease 
(N=1062207) 
n (%) 
     <28 weeks 11 (0.6) 6414 (0.6) 
     28-31 weeks 17 (0.9) 5706 (0.5) 
     32-33 weeks 13 (0.7) 6986 (0.7) 
     34-36 weeks 114 (6.1) 43500 (4.1) 
     37-38 weeks 559 (29.7) 235232 (22.2) 
     39-40 weeks 900 (47.8) 585023 (55.1) 
     41 weeks 240 (12.8) 163813 (15.4) 
     42+ weeks 28 (1.5) 15380 (1.5) 
Year of birth   
     2001-2003 409 (21.7) 245941 (23.2) 
     2004-2006 458 (24.3) 258158 (24.3) 
     2007-2009 519 (27.6) 277924 (26.2) 
     2010-2012 496 (26.4) 280184 (26.4) 
SEIFA=Socio economic indexes for areas 
^ 5 or less 
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Table 2: Maternal and neonatal outcomes by gallstone disease status among 1,064,089 pregnancies, 
New South Wales, 2001-2012 
Characteristics 
Gallstone disease 
(N=1882) 
n (%) 
No gallstone disease 
(N=1062207) 
n (%) 
Unadjusted 
Risk Ratio 
(95% CI)* 
Adjusted Risk 
Ratio 
(99% CI)* 
Antepartum haemorrhage 69 (3.7) 35364 (3.3) 1.1 (0.9, 
1.4) 
1.1 (0.8, 1.5) 
Preterm birth 155 (8.2) 62606 (5.9) 1.4 (1.2, 
1.6) 
1.3 (1.1, 1.6) 
     Spontaneous 69 (3.7) 36105 (3.4) 1.1 (0.9, 
1.4) 
1.1 (0.8, 1.4) 
     Planned 86 (4.6) 26488 (2.5) 1.8 (1.5, 
2.3) 
1.6 (1.2, 2.1) 
Mode of birth     
     Vaginal, non-
Instrumental 
1161 (61.7) 645292 (60.8) Reference Reference 
     Instrumental 160 (8.5) 118768 (11.2) 1.0 (1.0, 
1.0) 
1.0 (1.0, 1.0) 
     Caesarean – labour 245 (13.0) 126758 (11.9) 1.0 (1.0, 
1.0) 
1.0 (1.0, 1.1) 
     Caesarean – no labour 315 (16.8) 170922 (16.1) 1.0 (1.0, 
1.0) 
1.0 (1.0, 1.1) 
Maternal morbidity 55 (2.9) 18305 (1.7) 1.7 (1.3, 
2.2) 
1.6 (1.1, 2.3) 
Maternal readmission     
     for any reason 388 (20.6) 43253 (4.1) 5.1 (4.6, 
5.5) 
4.7 (4.2, 5.3) 
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     reasons other than 
cholecystectomy 
234 (12.4) 42805 (4.0) 3.1 (2.7, 
3.5) 
2.9 (2.4, 3.3) 
Postpartum haemorrhage 163 (8.7) 81789 (7.7) 1.1 (1.0, 
1.3) 
1.1 (0.9, 1.4) 
Apgar score     
     5 minutes less than 7 39 (2.1) 20934 (2.0) 1.1 (0.8, 
1.4) 
1.0 (0.7, 1.5) 
Small for gestational age 192 (10.3) 104325 (9.9) 1.0 (0.9, 
1.2) 
1.0 (0.9, 1.2) 
Large for gestational age 221 (11.8) 106877 (10.1) 1.2 (1.0, 
1.3) 
1.1 (0.9, 1.3) 
Neonatal morbidity 119 (6.3) 44988 (4.2) 1.5 (1.3, 
1.8) 
1.4 (1.1, 1.7) 
Neonatal length of stay, 
median (IQR) 
3 (2, 4) 3 (2, 4) 
 
 
Neonatal readmission 118 (6.3) 40830 (3.8) 1.6 (1.4, 
1.9) 
1.5 (1.2, 1.9) 
*Adjusted RR for gallstone disease relative to no gallstone disease 
Planned preterm birth includes births less than 37 weeks with labour induction or pre-labour 
caesarean section 
Multivariate model adjusted for maternal age, parity, hypertension, diabetes, socioeconomic status, 
maternal country of birth and baby’s year of birth 
 
  
Final version of this paper was published in Paediatric and Perinatal Epidemiology, 2017,31:522-530 
 
25 
 
Table 3: Hospitalisation and gallstone disease subtype among 1882 pregnancies, New South Wales, 
2001-2012 
Characteristics 
Gallstones 
without 
cholecystitis 
(N=1497) 
Gallstones with 
cholecystitis 
(N=308) 
Acute biliary 
pancreatitis 
(N=77) 
Gestational age at first presentation 
(weeks), median (IQR) 
27.3 (16.9, 34.9) 20.9 (10.6, 30.7) 24.9 (12.6, 31.1) 
Number of gallstone disease hospital 
admissions during pregnancy, 
mean(sd) 
1.3 (0.8) 1.2 (0.6) 1.3 (0.8) 
Maternal length of stay – gallstone 
disease admissions (days), mean(sd) 
3.8 (5.2) 4.3 (4.0) 6.1 (5.5) 
Pregnancies with 3 or more gallstone 
disease-related hospital admissions, 
n(%) 
112 (7.5) 31 (10.1) 14 (18.2) 
Management of gallstone disease 
during pregnancy 
   
     Antepartum cholecystectomy  123 (8.2) 91 (29.6) 25 (32.5) 
     Conservative management 1374 (91.8) 217 (70.5) 52 (67.5) 
Cholecystectomy during pregnancy    
     First presentation 95 (77.2) 77 (84.6) 20 (80.0) 
     Subsequent admissions 28 (22.8) 14 (15.4) ^ (20.0) 
Gestational age at time of 
cholecystectomy during pregnancy 
(weeks), median (IQR) 
15.4 
(7.9, 21.9) 
14.0 
(7.0, 22.7) 
18.9 
(14.1, 24.7) 
Time from first presentation to 10.0 2.0 6.0 
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antepartum cholecystectomy (days), 
median (IQR) 
(0.0, 42.0) (0.0, 11.0) (1.0, 11.5) 
Postpartum cholecystectomy* 251 (18.3) 47 (21.7) 14 (26.9) 
Where multiple gallstone disease conditions were coded for the same presentation, categorisation was 
based on the most severe condition coded.  Scale of severity (most to least severe): 1) Acute biliary 
pancreatitis, 2) Gallstones with cholecystitis, 3) Gallstones without cholecystitis 
^ 5 or less                    
* denominator = pregnancies with gallstone disease managed conservatively 
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Table 4:  Maternal and neonatal outcomes by management of gallstone disease during pregnancy  
Characteristics 
Cholecystectomy 
(n=239) 
Conservative 
management 
(n=1643) 
Unadjusted risk 
ratio 
(95% CI)* 
Adjusted risk 
ratio 
(99% CI)* 
Antepartum 
haemorrhage 
7 (2.9) 62 (3.8) 0.8 (0.4, 1.7) 0.8 (0.3, 2.4) 
Preterm birth 18 (7.5) 137 (8.3) 0.9 (0.6, 1.4) 0.9 (0.4, 1.7) 
     Spontaneous 12 (5.0) 57 (3.5) 1.4 (0.8, 2.6) 1.2 (0.5, 3.1) 
     Planned 6 (2.5) 80 (4.9) 0.5 (0.2, 1.2) 0.5 (0.2, 1.8) 
Mode of delivery     
     Vaginal, non-
instrumental 
147 (61.5) 1014 (61.8) Reference Reference 
     Instrumental 13 (5.4) 147 (9.0) 1.0 (0.9, 1.0) 1.0 (0.9, 1.1) 
     Caesarean – labour 28 (11.7) 217 (13.2) 1.0 (0.9, 1.1) 1.0 (0.9, 1.1) 
     Caesarean – no 
labour 
51 (21.3) 264 (16.1) 1.1 (1.0, 1.2) 1.1 (0.9, 1.3) 
Maternal morbidity 8 (3.4) 47 (2.9) 1.2 (0.6, 2.4) 1.4 (0.4, 4.3) 
Maternal readmission     
     for any reason 18 (7.5) 370 (22.5) 0.3 (0.2, 0.5) 0.4 (0.2, 0.7) 
     reasons other than 
cholecystectomy 
18 (7.5) 216 (13.2) 0.6 (0.4, 0.9) 0.6 (0.3, 1.2) 
Postpartum 
haemorrhage 
19 (8.0) 144 (8.8) 0.9 (0.6, 1.4) 0.9 (0.5, 1.7) 
Apgar score at 5 
minutes 
     Less than 7 
10 (4.2) 29 (1.8) 2.4 (1.2, 4.8) 2.6 (0.8, 8.7) 
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Characteristics 
Cholecystectomy 
(n=239) 
Conservative 
management 
(n=1643) 
Unadjusted risk 
ratio 
(95% CI)* 
Adjusted risk 
ratio 
(99% CI)* 
Small for gestational 
age 
24 (10.1) 168 (10.3) 1.0 (0.7, 1.5) 1.0 (0.5, 1.8) 
Large for gestational 
age 
30 (12.7) 191 (11.7) 1.1 (0.8, 1.6) 0.9 (0.5, 1.6) 
Neonatal morbidity 14 (5.9) 105 (6.4) 0.9 (0.5, 1.6) 0.9 (0.4, 1.9) 
Neonatal length of stay 
(days), median (IQR) 
3 (2, 4) 3 (2, 4) 
 
 
Neonatal readmission 15 (6.3) 103 (6.3) 1.0 (0.6, 1.7) 1.2 (0.5, 2.5) 
*Adjusted RR for cholecystectomy relative to conservative management 
Multivariate models adjusted for parity, gestational age at first gallstone admission, gallstone disease 
subtype, and presence of multiple types of gallstone disease. 
Planned preterm birth includes births less than 37 weeks with labour induction or pre-labour 
caesarean section 
 
 
